Interferon alpha (IFN α2a) therapy for herpes virus-associated inflammatory bowel disease (ulcerative colitis and Crohn's disease)

Hepato-Gastroenterology

Volumn 45, Issue 21, 1998, Pages 691-699

  Ruther, U ^a   Nunnensiek, C ^c   Muller, H A G ^a   Bader, H ^b   May, U ^a   Jipp, P ^a  

^a Center for Internal Medicine   (Germany)

^b Katharinenhospital   (Germany)

^c Klinik am Eichert ^*

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; MESALAZINE; METRONIDAZOLE; PREDNISOLONE; PREDNISONE; RECOMBINANT ALPHA2A INTERFERON; VIRUS DNA;

ADULT; AGED; ARTICLE; CELL NUCLEUS; CLINICAL ARTICLE; COLON; CROHN DISEASE; DIARRHEA; EPSTEIN BARR VIRUS; FEMALE; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; HERPES VIRUS; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; INTESTINE BIOPSY; INTESTINE MUCOSA; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REMISSION; SMALL INTESTINE; SUBCUTANEOUS DRUG ADMINISTRATION; SYMPTOM; TREATMENT OUTCOME; ULCERATIVE COLITIS;

ADULT; AGED; COLITIS, ULCERATIVE; CROHN DISEASE; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; DNA, VIRAL; HERPESVIRIDAE INFECTIONS; HERPESVIRUS 1, HUMAN; HERPESVIRUS 2, HUMAN; HERPESVIRUS 4, HUMAN; HERPESVIRUS 6, HUMAN; HUMANS; IN SITU HYBRIDIZATION; INFLAMMATORY BOWEL DISEASES; INTERFERON ALFA-2A; INTESTINAL MUCOSA; MIDDLE AGED; RESPIRATORY TRACT INFECTIONS;

EID: 0031828588     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (67)

1. Acheson ED, Truelove SC: Early weaning in the etiology of ulcerative colitis. BMJ 1961; 2:929-933.
2. Allison MC, Pounder RE: Cyclosporin for Crohn's disease. Aliment Pharmacol Ther. 1987; 1:39-43.
3. Balkwill FR: Peptide regulatory factors: Interferons. Lancet I 1989; 1060-1063.
4. Bartlett JG, Moon N, Chang TW, Taylor N, Onderdonk AB: Role of clostridium difficile in antibiotic-associated pseudomembranous colitis. Gastroenterology 1978; 75:778-782.
5. Bartnik W, Shorter RG: Inflammatory bowel disease: immunologic developments. In: Berk, J. E. (ed.) P; Development in Digestive Diseases. Philadelphia, Leo & Febiger 1980; 109.
6. Best WR, Becktel JM, Singleton JW, Kern F: Development of a Crohn's disease activity index (National Cooperative Crohn's Disease study). Gastroenterology 1976; 70:439-444.
7. Biemond I, Burnham WR, D'Amaro J, Langman MJS: HLA-A and -B antigens in inflammatory bowel disease. Gut 1968; 27: 934-941.
8. Blaser MJ, Berkowitz ID, LaForce FM., Cravens J, Reller LB, Wang WL: Campylobacter enteritis: clinical and epidemiologic features. Ann Intern Med 1979; 91:179-185.
9. Bolen, J. L., Zaminska, S. A., Greenough, W. B.: Clinical features in enteritis due to Vibrio parahemolyticus. Am J Med 1974; 57:638-641.
10. Bonnevie O: A socio-economic study of patients with ulcerative colitis. Scand J Gastroenterol 1967; 2:129-139.
11. Bradford WB, Noce PS, Ghutman LT: Pathologic features of enteric infection with yersinia enterocolitica. Arch. Pathol. 1974;98: 17-22.
12. Brinkmann V, Kristofic C: Regulation by corticosteroids of Th1 and Th2 cytokine production in human CD4-effector T cells generated from CD45 RO- and CD45 RO+ subsets. J. Immunol. 1995; 155:3322-3328.
13. Brook MG, Chan G, Yap I, Karayiannis P, Lever AM, Jacyna M, Main J, Thomas, HC: Randomised controlled trial of lymphoblastoid Interferon alfa in Europid men with chronic hepatitis B virus infection. BMJ 1989; 299:652-656.
14. Burnham, W. R., Lennard Jones, J. G., Stanford, J. I., Bird, R. G.: Mycobacteria as a possible cause of inflammatory bowel disease. Lancet II 1978; 693-696.
15. Butt, J. H., Lennard-Jones, J. E., Ritchie, J. K.: A practical approach to the risk of cancer in inflammatory bowel disease. Med Clin North Am 1980; 64:1203-1206.
16. Casini Raggi V, Kam L, Chong YJ, Fiocchi C, Pizarro TT, Cominelli F: Mucosal imbalance of IL-1 and IL-1 receptor antagonist in infammatory bowel disease. A novel mechanism of chronic intestinal inflammation. J Immunol 1995; 1545:2434-2440.
17. Champsaur H, Questizux E, Prevot J, Henry-Amar M, Goldszmidt D, Bourjouane M, Bach C: Rotavirus carriage, asymptomatic infection and disease in the first two years of life. I. Virus shedding. J. Infect. Dis. 1984; 149:667-674
18. Drobyski, W. R., Eberle, M., Majewski, D., Baater-Lowe, L. A.: Prevalence of human herpesvirus 6 variant A and B infections in bone marrow transplant recipients as determined by polymerase chain reaction and sequence specific oligonucleotide probe hybridization. J Clin Microbiol 1993; 31:1515-1520
19. Ekbom A, Wakefield AJ, Zack M, Adami HO: Perinatal measles infection and subsequent Crohn's disease. Lancet 1994; 344(8921):508-510.
20. Fais, S.: Spontaneous and stimulated interferons production by cultured lamina propria mononuclear cells in Crohn's disease. Gastroenterology 1989; 96:A145
21. Feiereis, H.: Colitis ulcerosa. In: Psychosomatische Medizin. Uexkull, Th. V. (ed.), 4. Aufl., Urban und Schwarzenberg, Munchen 1990: 782-789
22. Fiocchi, C., Kusegami, K., Trudel, J., Leberman, B. Y., Ouyang, Q., El-Youssef, M.: Immunocytotoxicity and lymphokines in inflammatory bowel disease. In: Goebell, H., Peskar, B. M., Malchow, H. (eds.): Inflammatory Bowel Diseases - Basic Research and Clinical Implications. Boston, MTP Press 1988: 113-120.
23. Giannella, R. A., Formal, S. B., Dammin, G. J., Collins, H.: Pathogenesis of salmonellosis. Studies of fluid secretion, mucosal invasion, and morphologic reaction in the rabbit ileum. J Clin Invest 1973; 52:441-453.
24. Gilman R, Islam M, Paschi S, Goleburn J, Ahmad F: Comparison of conventional and immunofluorescent techniques for the detection of entamoeba histolytica in rectal biopsies. Gastroenterology 1980; 78:435-439.
25. Greiner, J. W., Horan Hand, P., Wunderlich, D., Colche, D.: Radioimmunoassay for detection of changes in all surface tumor antigen expression induced by interferon. Methods Enzymol 1986; 199:682-688.
26. Gross, R. J.: Escherichia coli diarrhoea. J Infect Dis 1983; 7:177-182
27. Hadziselimovic F: Interferon (2a as a treatment for refractive inflammatory bowel disease: initial observations (Abstract). IBD Falk Symposium, Freiburg i.Br. (1990)
28. Hadziselimovic F, Emmons LR, Schaub U: Natural killer cell and large granular lymphocyte deficiency in gut of children with inflammatory bowel disease. Can. J. Gastroenterol 1990; 4:303-308.
29. Hamilton SR: Diagnosis and comparison of ulcerative colitis and Crohn's disease involving the colon. In: Norris, H. T. (ed.): Pathology of the Colon, Small Intestine and Anus. New York (1983) Churchill Livingstone, p. 1
30. Isaacs, A., Lindenmann, J.: Virus interference, I: the Interferon. Proc. R. Soc. Ser. B 1967; 47:258-341.
31. Janowitz, H. D., Sachar, D. B.: Inflammatory bowel disease. Adv Intern Med 1982; 27:205-246.
32. Kagnoff MF, Austin, RK, Hubert JJ, Bernardin JE, Dasarda DD: Possible role for a human adenovirus in the pathogenesis of celiac disease. J Exp Med 1984; 160:1544-1557.
33. Kangro HO, Chong SKF, Hardiman A, Heath RB, Walker-Smith JA: A prospective study of viral and mycoplasma infections in chronic inflammatory bowel disease. Gastroenterology 1990; 98:549-553.
34. Kirsner JB, Shorter RG: Recent developments in "non-specific" inflammatory bowel disease. N Engl J Med 1982; 306:775-785.
35. Langer JA, Pestka S: Interferon receptors. Immunol. Today 1988; 9:393-400.
36. Levine MM, DuPont HL, Formal SB et al: Pathogenesis of Shigella dysenteriae 1 shiga) dysentery. J. Infect. Dis. 1973; 127:261-270.
37. Lewkonia RM, McConnell RB: Familial inflammatory bowel disease - heredity or environment? Gut 1976; 17:235-241.
38. Mayberry JF, Rhodes J, Heatly, R. V.: Infections which cause ileocolic disease in animals: are they relevant to Crohn's disease? Gastroenterology 1980; 78:1080-1084.
39. Monk M, Mendeloff AI, Siegel CI, Lilienfeld A: An epidemiological study of ulcerative colitis and regional enteritis among adults in Baltimore. II. Social and demographic factors. Gastroenterology 1969; 56:847-857
40. Monk M, Mendeloff AI, Siegel CI, Lilienfeld A: An epidemiological study of ulcerative colitis and regional enteritis among adults in Baltimore. I. Hospital incidence and prevalence 1960 to 1963. Gastroenterology 1967; 53:198-210.
41. Mosmann T: Cytokines and immune regulation. In: Rich, R. R. (ed.): Clinical Immunology, Mosby: St. Louis 1995:217-230
42. Murrey CB: Psychogenic factors in the etiology of ulcerative colitis and bloody diarrhoea. Amer J Med Sci 1930; 180:239
43. Nielsen OH, Elmgren J, Ahnfelt-Ronne I: Serum interferon activity in inflammatory bowel disease. Arachidonic acid release and lipoxagenation activated (-class interferon in human neurophils. Infammation 1988; 12:169-179.
44. Nunnensiek C, Ruther U, Muller HAG, Ruppe W, Bader H, Luthgens M, Gfrorer S, Jipp R, Kruse-Jarres JD: Nachweis von EBV-und HSV(I+II)-DNS in the Ileum-und Kolonschleimhaut bei kolorektalen Karzinomen, Morbus Crohn und Colitis ulcerosa. Tumordiagn. u. Ther 1990; 11:212-218.
45. Ortaldo JR, Herbermann RB, Harvey C, Osheroff P, Pan YC, Kelder B, Pestka S: A species of human alpha interferon that lacks the ability to boost human natural killer activity. Proc. Natl. Acad. Sci. USA 81 (1984) 4926-4929.
46. Perrillo RP, Regenstein FG, Peters MG, DeSchryver-Kecskemeti K, Bodicky CJ, Campbell CR, Kuhns MC: Prednisone withdrawal followed by recombinant alpha interferon in the treatment of chronic type B hepatitis. A randomized, controlled trail. Ann. Intern Med 1988; 109:95-100.
47. Perrillo, R. P., Schiff, E. R., Davis, G. L et al: The hepatitis interventional therapy group: A randomized controlled trial of interferon alfa-2b alone and after prednisone withdrawal for the treatment of chronic hepatitis B. N. Engl. J. Med. 1990; 323:295-301.
48. Pullmann WE, Elsbury S, Kobayashi M, Hapel AJ, Doe WF: Enhanced mucosal cytokine production in inflammatory bowel disease. Gastroenterology 1995; 102:529-537.
49. Rasmussen SN, Binder V, Maier K, Bondesen S, Fischer C, Klotz U, Honore Hansen S, Huidberg EF: Treatment of Crohn's disease with peroral 5-aminosalicyl acid. Gastroenterology 1983; 85:1350-1353.
50. Rehberg E, Kelder B, Hoal EG, Pestka S: Specific molecular activities of recombinant and hybrid leukocyte interferons. J Biol Chem 1982; 257:11497-11502.
51. Rhodes, J., Ivanyi, J., Cozens, P.: Antigen presentation by human monocytes: effects of modifying major histocompatibility complex class II antigen expression and interleukin 1 production by using recombinant interferons and corticosteroids. Eur J Immunol 1986; 16:370-375.
52. Riemann, JR. Der chronisch-entzundliche Darm. Fortschr Med 1988; 106:191.
53. Rohr G, Kusterer K, Schule M, Gladisch R, Schwedes U, Teuber J, Usadel KH: Treatment for Crohn's disease and ulcerative colitis with 7S-immunoglobulin. Lancet II (1987) 170
54. Ruther, U., Nunnensiek, C., Muller, H. A. G., Rothe, B., Bader, H., Jipp, R.: Successful Treatment of Ulcerative Colitis with Interferone-alpha (IFN-(2a). Hepato-Gastroenterol. 40 (1993) Suppl. 1 pp. 32
55. Saracco, G., Mazzella, G., Rosina, F., Cancellierie, C., Lattore, V., Raise, E., Rocca, G., Giorda, L., Verme, G., Gasbarrini, G. et al.: A controlled trial of human lymphoblastoid interferon in chronic hepatitis B in Italy. Hepatology 3 (1989) 336-341
56. Shorter, R. G., Kirsner, J. B.: Immunology of idiopathic inflammatory bowel disease. In: Shorter, R. G., Kirsner, J. B. (eds.): Gastrointestinal Immunity for the Clinician. New York, Grune & Stratton (1985) pp. 171
57. Snijders, P. J., Schulten, E. A., Mullink, H., tenKate, R. W., Jiwa, M., van der Waal, I., Meijer, C., J., Walboomers, J. M.: Detection of human papillomavirus and Epstein-Barr virus DNA sequences in oral mucosa of HTV-infected patients by polymerase chain reaction. Am. J. Pathol. 137 (1990) 659-666
58. Taylor-Robinson, D., O'Morian, C. A., Thomas, B. J., Levi, A. J.: Low frequency of chlamydial antibodies in patients with Crohn's disease and ulcerative colitis. Lancet I (1979) 1162-1165
59. Thayer, W. R., Coutu, J. A., Chiodini et al.: Possible role of mycobacteria in inflammatory bowel disease. II. Mycobacteria antibodies in Crohn's disease. Dig. Dis. Sci. 29 (1984) 1080-1085
60. Thomas, H. C., Jewell, D. P.: Ulcerative colitis. In: Thomas, H. C., Jewell, D. P. (eds.): Clinical Gastrointestinal Immunology, Blackwell, Oxford (1979) pp. 137
61. Vantrappen, G., Agg, H. O., Penette, E., Geboes, K., Bertrand, P.: Yersinia enteritis and enterocolitis. Gastreoenterological aspects. Gastroenterology 72 (1977) 220-227.
62. Coremans, G., Billian, A., De Somer, P.: Treatment of Crohn's disease with interferon. A preliminary clinical trial. Act. Clin. Belg. 35 (1980) 238-242.
63. Wakefield, A. J., Fox, J. D., Sawyerr, A. M., Taylor et al.: Detection of Herpesvirus DNA in the Large Intestine of Patients With Ulcerative Colitis and Crohn's Disease Using the nested Polymerase Chain Reaction. J. Med. Virol. 38 (1992) 183-190.
64. Wakefield, A. J., Pittilo, R. M., Sim et al: Evidence of persistent measles virus infection in Crohn's disease. J. Med. Virol. 39(4) (1993) 345-353.
65. Walker, A. R. P., Segal, I.: Epidemiology of noninfective intestinal diseases in various ethnic groups in South Africa. Isr. J. Med. Sci. 15 (1979) 309-313.
66. Wirth HP, Zala G, Meyenberger Ch, Jost Ammann R, Munch R: Alpha-Interferon-Therapie bei M. Crohn: erste klinische Erfahrungen. Schweiz. Med. Wochenschr. 123 (1993) 1384-1388.
67. Zipeta, D., Silini, E., Parea et al.: Identification of human cytomegalovirus isolated by the polymerase chain reaction. Microbiologica 13 (1990) 297-304.